Hoth Inks Research Agreement With North Carolina State University For Study of Preclinical Candidate To Treat Mast Cell Cancers
Hoth Therapeutics, Inc. (NASDAQ: HOTH) announced an oncology R&D collaboration on Tuesday.
Hoth Therapeutics Reports 2 Contracts With WuXi AppTec’s STA Pharma For Process Development, Manufacturing Of Active Pharmaceutical Ingredient, Formulation Of Drug Product For Continued Development, Commercialization Of HT-KIT Therapeutic
WuXi STA, is a leading manufacturer of GMP morpholino oligonucleotides (PMOs)
NEW YORK, Nov. 8, 2021 /PRNewswire/ -- Hoth Therapeutics, Inc., (NASDAQ:HOTH) a patient focused biopharmaceutical company,
Hoth Therapeutics Extends Partnership Agreement With REPROCELL; Terms Not Disclosed
-- Hoth Therapeutics, Inc. (NASDAQ:HOTH) has extended its partnership agreement with REPROCELL to assess the effect of the HT-003 therapeutic platform in inflammatory bowel disease (IBD). Fresh explants of
Hoth Therapeutics Receives Approval to Commence Cohort 2 in Clinical Trial of BioLexa for the Treatment of Atopic Dermatitis in Humans
NEW YORK, NY October 12, 2020 / PR Newswire / Hoth Therapeutics, Inc.
Hoth Therapeutics Shares Spike Higher; Co Says Receives Approval To Commence Cohort In Clinical Trial Of BioLexa For Treatment Of Atopic Dermatitis Patients
Hoth Therapeutics, Inc. (NASDAQ: HOTH), a biopharmaceutical company, today announced that is has received Human Research Ethics Committee (HREC) clearance to commence cohort 2 of the Phase 1b clinical
The Daily Biotech Pulse: Moderna Invests In Africa, Amgen Announces Neuroscience R&D Collaboration, Decision Day For Chemocentryx, Biophytis To Restate Results
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Oct. 6)
Alkido Pharma Trading 30% Below Cash Value Despite Positive Indications
Photo by Joshua Mayo on Unsplash
The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer’s Sleep Disorder Drug Filing Accepted For Review, Voyager’s Licensing Options Deal
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Oct. 5)
Hoth Therapeutics Submits To Ethics Committee For Approval To Initiate Patient Cohort 2 In BioLexa Clinical Trial
Hoth Therapeutics, Inc. (NASDAQ:HOTH), a patient-focused biopharmaceutical company, announced today that a Safety Review Committee (SRC) has reviewed the safety data from the first cohort of healthy subjects and
Hoth Therapeutics Submits To Ethics Committee For Approval To Initiate Patient Cohort 2 In BioLexa Clinical Trial
Hoth Therapeutics, Inc. (NASDAQ:HOTH), a patient-focused biopharmaceutical company, announced today that a Safety Review Committee (SRC) has reviewed the safety data from the first cohort of healthy subjects and